S09 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sutro Biopharma Inc

Watchlist Manager

Watchlist

Price: 12.5 EUR -5.3% Market Closed

Market Cap: €1B

S	Sutro Biopharma Inc F:S09	US
E	Enbridge Inc XHAM:EN3	CA
O	OPKO Health Inc BMV:OPK	US
	Telkom Indonesia (Persero) Tbk PT F:PTI	ID
	Ibex Ltd F:IB7	US
L	Leifheit AG XMUN:LEI	DE
	Xtant Medical Holdings Inc F:XMS	US
	Hudson Pacific Properties Inc F:HP9	US
B	Brighthouse Financial Inc F:BROC	US
C	Chalice Mining Ltd XMUN:C8U	AU

Profitability Summary

Sutro Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-87%

Negative 3Y Average Operating Margin

-168%

Operating Margin is Increasing

-279% > -87%

Negative Net Margin

-154%

Negative 3Y Average Net Margin

-194%

Net Margin is Increasing

-251% > -154%

Negative Free Cash Flow Margin

-153%

Negative 3Y Average Free Cash Flow Margin

-180%

Declining Free Cash Flow Margin

-100% > -153%

Exceptional ROE

331%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-242%

Declining ROIC

-147% > -177%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.